Understanding Isv Mini Symposium On Pneumococcal Vaccines
Let's dive into the details surrounding Isv Mini Symposium On Pneumococcal Vaccines. Featuring: Dr. Kathleen McElwee (Pfizer) Title: Impact of
Key Takeaways about Isv Mini Symposium On Pneumococcal Vaccines
- Introduction; PCV13 Impact on IPD and serotype distribution for the remaining disease burden ; Incidence of non-Invasive ...
- PCV13 impact on nasopharyngeal carriage among children and adults, PCV13 impact on invasive
- Introduction; Considerations for PCV13 use among adults 65 years or older and summary of the Evidence to Recommendations ...
- Epidemiology of pneumococcal disease and
- Introduction by Dr. N Bennett. PCV13 herd effect by Dr. M Moore. Reduced dose schedule: review of evidence by Ms. T Pilishvili.
Detailed Analysis of Isv Mini Symposium On Pneumococcal Vaccines
Featuring: Dr. Nnenna Chime (Sanofi) Introduction & Moderator Professor Albert Osterhaus (Center of Infection Medicine and ... Featuring: Corey Fang, Global Medical Affairs Lead | External Scientific Relations | Infectious Disease Portfolio, AstraZeneca ... Dr. Glenda Gray, (South African Medical Research Council) Title: Why HIV
Welcome; Agency Updates;
That wraps up our extensive overview of Isv Mini Symposium On Pneumococcal Vaccines.
